ArticleJournal of gynecologic oncology2026

FUS-stabilized USP7 facilitates the bevacizumab resistance of ovarian cancer through deubiquitinating PTK2.

Xianping Wen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.